| 3.52 0 (0%) | 07-21 16:00 | |||||||||||||
|
|
| Short term |   |
|||
| Mid term |  |
|||
| Targets | 6-month : | 3.9 |
1-year : | 4.53 |
| Resists | First : | 3.34 |
Second : | 3.88 |
| Pivot price | 3.06  |
|||
| Supports | First : | 2.48 |
Second : | 2.06 |
| MAs | MA(5) : | 3.23 |
MA(20) : | 3.04 |
| MA(100) : | 4.92 |
MA(250) : | 21.88 |
|
| MACD | MACD : | -0.1 |
Signal : | -0.2 |
| %K %D | K(14,3) : | 54.6 |
D(3) : | 55.9 |
| RSI | RSI(14): 46.3 |
|||
| 52-week | High : | 97.5 | Low : | 2.48 |
Price has closed below its short-term moving average. Short-term moving average is currently below mid-term; and below long-term moving average. From the relationship between price and moving averages: This stock is BEARISH in short-term; and BEARISH in mid-long term.[ WGRX ] has closed above bottom band by 47.3%. Bollinger Bands are 64.6% narrower than normal. The narrow width of the bands suggests low volatility as compared to its normal range. The bands have been in this narrow range for 32 bars. This is a sign that the market may be about to initiate a new trend.
| If tomorrow: | Open lower | Open higher |
| High: | 3.88 - 3.9 | 3.9 - 3.92 |
| Low: | 2.92 - 2.94 | 2.94 - 2.96 |
| Close: | 2.99 - 3.03 | 3.03 - 3.06 |
Wellgistics Health, Inc. functions as a primary wholesaler and distributor of pharmaceutical products throughout the United States, catering to both drug manufacturers and independent retail pharmacies. Its extensive product catalog includes a variety of generic and brand-name pharmaceuticals, alongside over-the-counter healthcare and consumer merchandise. The company also delivers a suite of third-party logistics (3PL) services, encompassing warehousing, inventory control, pick-and-pack operations, and shipping solutions, specifically designed for small to mid-sized pharmaceutical producers. Furthermore, Wellgistics manages the DelivMeds platform, an integrated pharmaceutical hub that streamlines prescription transfers and offers essential backend clinical concierge support to its network of independent pharmacies. It also runs a specialized retail community service. Established in 2022 and headquartered in Tampa, Florida, the organization adopted its current name, Wellgistics Health, Inc., in October 2024, having previously operated as Danam Health, Inc.
Tue, 04 Aug 2026
DataMEDS AI (WGRX) LOI could give new partners 84.6% ownership stake - stocktitan.net
Tue, 28 Jul 2026
Wellgistics Health Terminates Equity Line of Credit to Further Support Growth Strategy - Democrat and Chronicle
Thu, 23 Jul 2026
DataMEDS AI Officially Begins Trading Under Stock Symbol 'MEDS' on the NASDAQ Capital Markets - Bergen Record
Thu, 23 Jul 2026
Wellgistics Health Inc. (WGRX) Q1 2026 Earnings: Net Loss of $0.07 Per Share, No Revenue Disclosed - Share Dilution Risk - careplusvn.com
Tue, 21 Jul 2026
WELLGISTICS HEALTH, INC. OFFICIALLY CHANGES CORPORATE NAME TO DATAMEDS AI, INC. - Yahoo Finance
Thu, 16 Jul 2026
Rubenstein Public Relations Named Agency of Record for Wellgistics Health, Inc. - GlobeNewswire
| Price to Book Value: P/BV, a ratio used to compare book value to its current market price, to gauge whether a stock is valued properly. |
Underperform |
| Price to Earnings: PE, the ratio for valuing a company that measures its current share price relative to its earnings per share (EPS). |
Underperform |
| Discounted cash flow: DCF, a valuation method used to estimate the value of an investment based on its expected future cash flows. |
Neutral |
| Return on Assets: ROA, indicates how profitable a company is in relation to its total assets, how efficiently uses assets to generate a profit. |
Underperform |
| Return on Equity: ROE, a measure of financial performance calculated by dividing net income by equity. a gauge of profitability and efficiency. |
Outperform |
| Debt to Equity: evaluate financial leverage, reflects the ability of equity to cover outstanding debts in the event of a business downturn. |
Underperform |
|
Exchange:
NASDAQ
|
|
|
Sector:
Healthcare
|
|
|
Industry:
Medical - Distribution
|
|
| Shares Out | 52 (M) |
| Shares Float | 1 (M) |
| Held by Insiders | 68.3 (%) |
| Held by Institutions | 1.7 (%) |
| Shares Short | 105 (K) |
| Shares Short P.Month | 445 (K) |
| EPS | -43.87 |
| EPS Est Next Qtrly | 0 |
| EPS Est This Year | 0 |
| EPS Est Next Year | 0 |
| Book Value (p.s.) | 0 |
| Profit Margin | 0 % |
| Operating Margin | -385.8 % |
| Return on Assets (ttm) | -79.2 % |
| Return on Equity (ttm) | 0 % |
| Qtrly Rev. Growth | -85.6 % |
| Gross Profit (p.s.) | -0.14 |
| Sales Per Share | 0.27 |
| EBITDA (p.s.) | -1.03 |
| Qtrly Earnings Growth | 0 % |
| Operating Cash Flow | -13 (M) |
| Levered Free Cash Flow | -7 (M) |
| PE Ratio | -0.07 |
| PEG Ratio | 0 |
| Price to Book value | 0 |
| Price to Sales | 11.22 |
| Price to Cash Flow | -12.19 |
| Dividend | 0 |
| Forward Dividend | 0 |
| Dividend Yield | 0% |
| Dividend Pay Date | Invalid DateTime. |
| Ex-Dividend Date | Invalid DateTime. |
|
|
|
|
|
|
|
|
|